Latest News for: h-iia

Edit

Schedule Announced for H-IIA Launch Vehicle to Deliver Inmarsat’s First I-6 Satellite to Geosynchronous Orbit (Mitsubishi Heavy Industries Ltd)

Public Technologies 04 Nov 2021
Schedule Announced for H-IIA Launch Vehicle to Deliver ... (MHI) announce that the launch of Inmarsat's first satellite in the Inmarsat-6 fleet (I-6 F1) by MHI's H-IIA Launch Vehicle No ... We are committed to providing highly reliable launch services for this 45th mission of H-IIA, following the success of previous missions.
Edit

Mr. Endo Kazuyuki, Store Manager of MUJI iias Kasugai / Mr. Hayashi Yoshihiro, Assistant Store Manager of MUJI iias Kasugai (Ryohin Keikaku Co Ltd)

Public Technologies 02 Nov 2021
Endo Kazuyuki, Store Manager of MUJI iias Kasugai / Mr. Hayashi Yoshihiro, Assistant Store Manager of MUJI iias Kasugai ... Endo (Store Manager of MUJI iias Kasugai) and Mr. Hayashi (Assistant Store Manager of MUJI iias Kasugai) to talk about the episodes leading up to the opening of ...
Edit

Q&A; with the IIA and Qontigo: ESG indices need to balance regulatory needs, investment objectives through customized solutions (Qontigo GmbH)

Public Technologies 01 Nov 2021
In July, the Index Industry Association (IIA) presented its first global ESG survey, a poll undertaken to gain a deeper understanding of the evolving role, challenges and opportunities of sustainability investment strategies in the asset-management industry ... Rick Redding, IIA.
Edit

Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 ...

Nasdaq Globe Newswire 28 Oct 2021
Phase IIa combination trial with its lead drug candidate lanifibranor and the SGLT2 inhibitor empagliflozin ...
Edit

The Institute of Internal Auditors (IIA) Asks Greek Government to Withdraw Proposed Legislation that Impedes Independent Internal Audit

PR Newswire 28 Oct 2021
Representatives of The IIA's Global headquarters and IIA Greece are scheduled to meet with the Minister of Development and Investments on Friday to discuss their concerns and outline a potential resolution ... This is all unnecessary given the role of The IIA and IIA-Greece in overseeing the profession.
Edit

IiAS flags Rs 200-cr debt raising plan by Inox Wind

Financial Express 27 Oct 2021
The proxy advisory firm cited high equity dilution at current stock price, and increase in leverage in case of debt raise as the reason for flagging against the fundraise ... .
Edit

Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes (Inventiva SA)

Public Technologies 27 Oct 2021
... Phase IIa combination trial with its lead drug candidate lanifibranor and the SGLT2 inhibitor empagliflozin in patients with T2D and non-cirrhotic NASH.
Edit

InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with ...

The Associated Press 27 Oct 2021
IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announces positive data from the third cohort of patients in the Phase IIa open-label study with vilobelimab in Pyoderma Gangraenosum (PG).
Edit

InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum - Form 6-K (Inflarx NV)

Public Technologies 27 Oct 2021
) InflaRx Announces Positive Data from Third Cohort of Phase IIa Open-Label Study with Vilobelimab in Pyoderma Gangraenosum ... system, announces positive data from the third cohort of patients in the Phase IIa open-label study with vilobelimab in Pyoderma Gangraenosum (PG).
Edit

Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in patients with NASH and type 2 diabetes - Form 6-K (Inventiva SA)

Public Technologies 27 Oct 2021
Inventiva announces the design of LEGEND, a Phase IIa combination trial with lanifibranor and SGLT2 inhibitor empagliflozin in ... Phase IIa combination trial with its lead drug candidate lanifibranor and the SGLT2 inhibitor empagliflozin in patients with T2D and non-cirrhotic NASH.
Edit

Launch Result of the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries aboard QZS-1R (Mitsubishi Heavy Industries Ltd)

Public Technologies 26 Oct 2021
Launch Result of the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries aboard QZS-1R ... Mitsubishi Heavy Industries, Ltd.(MHI) has launched the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries ...
Edit

MUJI iias Kasugai Opened (Ryohin Keikaku Co Ltd)

Public Technologies 26 Oct 2021
) StoresSustainability2021.10.25. MUJI iias Kasugai Opened. On September 22nd, MUJI iias Kasugai has opened in Kasugai city, Aichi prefecture. This is the largest MUJI store with a sales floor area of approximately 5455 ㎡ ... Customers can try out all MUJI storage products on the sales floor ... Stay tuned for MUJI iias Kasugai in the future! ... Disclaimer ... Ltd.
Edit

Launch Time of the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries aboard QZS-1R (Mitsubishi Heavy Industries Ltd)

Public Technologies 24 Oct 2021
Launch Time of the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries aboard QZS-1R ... Mitsubishi Heavy Industries hereby announces the launch time of the H-IIA Launch Vehicle No. 44 (H-IIA F44) which carries ...
×